Morning Overview on MSN
A one-shot gene edit safely lowered cholesterol in its first human trial
A single infusion of an experimental gene-editing therapy called VERVE-102 lowered LDL cholesterol in people with dangerously high lipid levels, marking the first time in vivo base editing of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results